Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.

Stem cells translational medicine·2026
Same author

Covalent Inhibitors of Monoacylglycerol Lipase Induce Conformational Changes and Proteasomal Degradation.

Journal of the American Chemical Society·2026
Same author

A bacterial family of fatty acid acyltransferases related to the <i>Shigella</i> effector IcsB.

mBio·2026
Same author

Unnatural Amino Acid and Emerging Chemistry Approaches to Map RNA-Protein Interactions.

Angewandte Chemie (International ed. in English)·2025
Same author

SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.

Virology·2025
Same author

miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors.

Viruses·2025

Related Experiment Video

Updated: Jun 30, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.9K

Monitoring SARS-CoV-2 Nsp13 helicase binding activity using expanded genetic code techniques.

Eryn Lundrigan1, Christine Hum1, Nadine Ahmed1

  • 1Department of Chemistry and Biomolecular Sciences, University of Ottawa Ottawa Ontario K1N 6N5 Canada john.pezacki@uottawa.ca.

RSC Chemical Biology
|May 1, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed a new method to study the SARS-CoV-2 Nsp13 helicase using fluorescent labeling. This technique helps understand enzyme activity and could lead to new pan-coronavirus therapies.

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.2K
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

1.6K

Related Experiment Videos

Last Updated: Jun 30, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.2K
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

1.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • The SARS-CoV-2 Nsp13 helicase is crucial for viral replication and a potential target for broad-spectrum coronavirus treatments.
  • Understanding its binding and unwinding mechanisms is key to developing effective therapeutics.

Purpose of the Study:

  • To develop a method for site-specific fluorescent labeling of the Nsp13 helicase using non-canonical amino acids.
  • To investigate the enzyme's substrate binding and translocation dynamics using Förster resonance energy transfer (FRET).

Main Methods:

  • Genetic code expansion was used to incorporate *p*-azido-l-phenylalanine (AzF) into Nsp13 at five specific sites.
  • The resulting Nsp13-AzF was labeled with a Cy5 fluorophore.
  • FRET assays were employed to monitor enzyme-substrate interactions and translocation.

Main Results:

  • Site-specific incorporation of AzF and Cy5 labeling did not impede Nsp13 helicase activity.
  • FRET-based assays successfully monitored the binding dynamics of labeled Nsp13 constructs to nucleic acid substrates.
  • The study demonstrated distance-dependent binding interactions.

Conclusions:

  • This approach enables direct monitoring of Nsp13 helicase binding activity.
  • The method offers a novel platform for screening inhibitors of this essential viral enzyme.
  • This research contributes to the development of potential pan-coronavirus therapeutics.